Simulations Plus (NASDAQ:SLP) offers advanced modeling software for the pharmaceutical and biotechnology industries within nasdaq today.

Drug developers face unique challenges in pediatric rare disease trials, including small and geographically dispersed patient populations, strict ethical limits on sampling and sparse early clinical ...

During his more than two decades with Nvidia, Rev Lebaredian has had a ringside seat to the show that has been the evolution of modern AI, from the ...

The U.S. Air Force has awarded Northrop Grumman the potential $972 million firm-fixed-price, time and materials Air Force Modeling and Simulation support services, or AFMS3, contract. Air Force ...